| Page 2 of 2 < |
Health Highlights: June 14, 2008
|
TOOLBOX
   Resize
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
Who's Blogging  |
The review, mandated by Congress, seems to support criticism by advocates and some members of Congress that the health care system needs to do more to help female veterans, theAPreported.
Any discrepancies in care are unacceptable and the agency is aggressively tackling the issue, said Dr. William E. Duncan, associate deputy undersecretary for health for quality and safety at the Department of Veterans Affairs.
"We're striving to understand the reason for these health disparities and to eliminate differences in veterans' health care based on personal characteristics," Duncan told theAP.
Currently, women account for about five percent of the VA's population. But that percentage is expected to nearly double in the next two years as more female veterans return home from Iraq and Afghanistan, the wire service said.
-----
Psoriasis Drug Could Raise Risk of Cancer: FDA
While the Johnson & Johnson drug ustekinumab may be effective in treating moderate-to-severe psoriasis, it also may raise users' risk of cancer, the U.S. Food and Drug Administration warned Friday.
On its Web site, the agency said it probably needed to evaluate additional safety data before deciding whether the skin-disease drug increased the likelihood of cancer, theWall Street Journalreported.
"The is a question whether a larger number of subjects, followed for longer periods might better inform the long-term safety of use of ustekinumab," the agency said.
An FDA advisory committee of experts on Tuesday is scheduled to decide whether to recommend whether to approve the drug, the newspaper said. The full agency isn't bound to follow the recommendations of its expert panels, but generally does.
-----
EPA's Proposed Lead Standards May Not Be Adequate: Experts
The U.S. Environmental Protection Agency's proposed new standards for lead air pollution may not be adequate to protect public health, according to some experts who attended a public meeting in Baltimore.
The meeting is one of a series being held by the EPA to gather input on its proposal to reduce the current standard of 1.5 micrograms of lead per cubic meter of air to between 0.10 micrograms and 0.30 micrograms per cubic meter of air.
The standard should be set below 0.10 micrograms, Frank O'Donnell, president of the nonprofit group Clean Air Watch, told the EPA panel on Thursday,The Baltimore Sunreported.
"Lead is a very toxic pollutant that steals IQ points from children," O'Donnell said.
"We're pleased the EPA is tightening the standards, but they should be set at the higher level," said Gary Ewart, director of government relations for the American Thoracic Society, theSunreported.
The EPA will accept written comments on the proposed standards until July 21 and is expected to adopt the new standards on Sept. 15, the newspaper said.
